Skip to content

LBRX LBRX Total Liabilities & Equity

Total Liabilities & Equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Alkermes logo
AlkermesALKS
$4.26B+105%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$418.79M
Alto Neuroscience logo
Alto NeuroscienceANRO
$276.26M+60.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$278.58M+61.3%
Opko Health logo
Opko HealthOPK
$1.86B-12.8%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+163%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's total liabilities & equity?
LBRX (LBRX) reported total liabilities & equity of $393.48M in Q1 2026.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.